(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

C68H107NO13 — CID 165261377

IUPAC(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCC
InChIInChI=1S/C68H107NO13/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-60(73)69-56(57(72)51-49-47-45-43-41-14-12-10-8-6-4-2)55-79-67-65(78)63(76)66(59(54-71)81-67)82-68-64(77)62(75)61(74)58(53-70)80-68/h5,7,11,13,16-17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-43,49,51,56-59,61-68,70-72,74-78H,3-4,6,8-10,12,14-15,18,21,24,27,30,33,36,39,44-48,50,52-55H2,1-2H3,(H,69,73)/b7-5-,13-11-,17-16-,20-19-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,42-40-,43-41+,51-49+
InChIKeyNIUIAIFWZFJKSH-SCUZZZJBSA-N
MW1146.60 g/mol
LogP11.11
Rot. Bonds46

About (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide (PubChem CID 165261377) has the molecular formula C68H107NO13 and a molecular weight of 1146.60 g/mol. Its IUPAC name is (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide.

Molecular Properties

Compound Name(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
PubChem CID165261377
Molecular FormulaC68H107NO13
Molecular Weight1146.60 g/mol
Exact Mass1145.77
IUPAC Name(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCC
InChIInChI=1S/C68H107NO13/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-60(73)69-56(57(72)51-49-47-45-43-41-14-12-10-8-6-4-2)55-79-67-65(78)63(76)66(59(54-71)81-67)82-68-64(77)62(75)61(74)58(53-70)80-68/h5,7,11,13,16-17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-43,49,51,56-59,61-68,70-72,74-78H,3-4,6,8-10,12,14-15,18,21,24,27,30,33,36,39,44-48,50,52-55H2,1-2H3,(H,69,73)/b7-5-,13-11-,17-16-,20-19-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,42-40-,43-41+,51-49+
InChIKeyNIUIAIFWZFJKSH-SCUZZZJBSA-N
XLogP11.11
TPSA227.86 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds46
Heavy Atoms82
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001146.60
LogP ≤ 511.11
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The IUPAC name of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide (CID 165261377) is (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide.
What is the SMILES notation for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The canonical SMILES for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCC.
What is the InChIKey of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
The InChIKey is NIUIAIFWZFJKSH-SCUZZZJBSA-N. The full InChI is InChI=1S/C68H107NO13/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-32-33-34-35-36-37-38-39-40-42-44-46-48-50-52-60(73)69-56(57(72)51-49-47-45-43-41-14-12-10-8-6-4-2)55-79-67-65(78)63(76)66(59(54-71)81-67)82-68-64(77)62(75)61(74)58(53-70)80-68/h5,7,11,13,16-17,19-20,22-23,25-26,28-29,31-32,34-35,37-38,40-43,49,51,56-59,61-68,70-72,74-78H,3-4,6,8-10,12,14-15,18,21,24,27,30,33,36,39,44-48,50,52-55H2,1-2H3,(H,69,73)/b7-5-,13-11-,17-16-,20-19-,23-22-,26-25-,29-28-,32-31-,35-34-,38-37-,42-40-,43-41+,51-49+.
What are the key properties of (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide?
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide has a molecular weight of 1146.60 g/mol, XLogP of 11.11, 46 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide is sourced from PubChem (CID 165261377), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).